C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction
- 9 February 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (4) , 608-616
- https://doi.org/10.1016/j.jacc.2004.10.067
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Ventricular Remodeling After Infarction and the Extracellular Collagen MatrixCirculation, 2003
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Effects of Intravenously Administered C-type Natriuretic Peptide in Humans: Comparison with Atrial Natriuretic Peptide.Hypertension Research, 1998
- C-Type Natriuretic Peptide Inhibits Intimal Thickening after Vascular InjuryAnnals of the New York Academy of Sciences, 1994
- ATRIAL NATRIURETIC FACTOR AND RELATED PEPTIDE HORMONESAnnual Review of Biochemistry, 1991
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophyCardiovascular Research, 1988
- Transforming Growth Factor Beta-1 in Acute Myocardial Infarction in RatsGrowth Factors, 1988
- Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension.Circulation, 1983
- Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.Circulation, 1979